Cellerant Therapeutics Lands $2,094,341 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=13911eae-097f-4d16-8b6b-4e87f04f48ab&Preview=1
Date
9/24/2012
Company Name
Cellerant Therapeutics
Mailing Address
1561 Industrial Road San Carlos, CA 94070
Company Description
Cellerant Therapeutics Inc. is a clinical-stage biotechnology company developing and commercializing the use of hematopoietic (blood-forming) stem cell-based therapies for the treatment of a variety of cancers and autoimmune diseases.
Website
http://www.cellerant.com
Transaction Type
Venture Equity
Transaction Amount
$2,094,341
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. Includes conversion of $1,144,342 of principal and interest from convertible promissory notes. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed